NURR1 polymorphisms may also be implicated in the etiology of disorders characterized by altered dopaminergic signaling, such as attention-deficit/hyperactivity disorder, schizophrenia and PD. This evidence concerns the gene NR4A2 and attention deficit-hyperactivity disorder.